Cell Diversity in Barrett’s Oesophagus Patients Good Predictor of Cancer Risk

Cell Diversity in Barrett’s Oesophagus Patients Good Predictor of Cancer Risk

Gastroenterology September 26, 2016 at 9:12 AM 0 comments

The genetic diversity measured between the cells affected by Barrett’s oesophagus has been found to be a good predictor of which patients are at a high risk of developing oesophageal cancer. This finding could offer greater quality of life to patients with Barrett’s oesophagus and save costs for healthcare providers.Read More

Nanotechnology Applied to Ginger Offers Novel Treatment for Bowel Disease

Nanotechnology Applied to Ginger Offers Novel Treatment for Bowel Disease

Gastroenterology September 26, 2016 at 9:11 AM 0 comments

NANOPARTICLES derived from ginger have been used to produce a beneficial effect in the treatment of inflammatory bowel disease (IBD), offering a novel approach provides an alternative to conventional treatments that could easily be developed for large-scale production due to its relatively low cost. Scientists used ginger-derived nanoparticles (GDNPs), toRead More

Nanotechnology Applied to Ginger Offers Novel Treatment for Bowel Disease

Nanotechnology Applied to Ginger Offers Novel Treatment for Bowel Disease

Gastroenterology September 26, 2016 at 9:11 AM 0 comments

NANOPARTICLES derived from ginger have been used to produce a beneficial effect in the treatment of inflammatory bowel disease (IBD), offering a novel approach provides an alternative to conventional treatments that could easily be developed for large-scale production due to its relatively low cost. Scientists used ginger-derived nanoparticles (GDNPs), toRead More

Scientists Mobilise Nanorobots to Fight Against Cancer

Scientists Mobilise Nanorobots to Fight Against Cancer

Oncology September 19, 2016 at 9:28 AM 0 comments

SWARMS of magneto-aerotactic bacteria equipped with covalently-bound drug-containing nanoliposomes have been administered into the bloodstream to successfully deliver treatment into hypoxic regions of cancerous tumours. Magneto-aerotactic bacteria tend to travel along local magnetic field lines and toward areas with low oxygen concentration, which are commonly resistant to standard therapies. TheseRead More

Scientists Mobilise Nanorobots to Fight Against Cancer

Scientists Mobilise Nanorobots to Fight Against Cancer

Oncology September 19, 2016 at 9:28 AM 0 comments

SWARMS of magneto-aerotactic bacteria equipped with covalently-bound drug-containing nanoliposomes have been administered into the bloodstream to successfully deliver treatment into hypoxic regions of cancerous tumours. Magneto-aerotactic bacteria tend to travel along local magnetic field lines and toward areas with low oxygen concentration, which are commonly resistant to standard therapies. TheseRead More

CRISPR Genome Editing Allows Blood Cells to Resist Sickle Cell Disease

CRISPR Genome Editing Allows Blood Cells to Resist Sickle Cell Disease

Hematology, Oncology September 19, 2016 at 9:27 AM 0 comments

INNOVATIVE CRISPR genome editing has been used to inhibit the pathological morphology of red blood cells caused by sickle cell disease, offering a new therapeutic approach for the treatment of a range of blood disorders. Sickle cell disease inhibits the ability of erythrocytes to deliver oxygen around the body, byRead More

CRISPR Genome Editing Allows Blood Cells to Resist Sickle Cell Disease

CRISPR Genome Editing Allows Blood Cells to Resist Sickle Cell Disease

Oncology September 19, 2016 at 9:27 AM 0 comments

INNOVATIVE CRISPR genome editing has been used to inhibit the pathological morphology of red blood cells caused by sickle cell disease, offering a new therapeutic approach for the treatment of a range of blood disorders. Sickle cell disease inhibits the ability of erythrocytes to deliver oxygen around the body, byRead More

Blocking of CD47 Protein Found to be Effective Approach Against Skin Cancer

Blocking of CD47 Protein Found to be Effective Approach Against Skin Cancer

Dermatology September 12, 2016 at 9:25 AM 0 comments

SCIENTISTS have found that blocking the signalling of the CD47 protein within specific populations of cancerous cells is an effective approach for stopping the spread of metastatic melanoma. A research team in the USA discovered that the blockade of anti-phagocytic signals transmitted by the CD47 cell surface protein on melanomaRead More

Blocking of CD47 Protein Found to be Effective Approach Against Skin Cancer

Blocking of CD47 Protein Found to be Effective Approach Against Skin Cancer

Dermatology September 12, 2016 at 9:25 AM 0 comments

SCIENTISTS have found that blocking the signalling of the CD47 protein within specific populations of cancerous cells is an effective approach for stopping the spread of metastatic melanoma. A research team in the USA discovered that the blockade of anti-phagocytic signals transmitted by the CD47 cell surface protein on melanomaRead More

Adalimumab Improves Symptoms of Inflammatory Disease at First Stage of Clinical Trials

Adalimumab Improves Symptoms of Inflammatory Disease at First Stage of Clinical Trials

Dermatology September 12, 2016 at 9:24 AM 0 comments

THE RESULTS of two Phase III clinical trials have shown that the tumour necrosis factor (TNF)-inhibitor adalimumab can improve the symptoms of hidradenitis suppurativa (HS). The findings of the PIONEER I and PIONEER II trials showed that HS patients receiving weekly doses of adalimumab had significantly higher response rates ofRead More